Fresenius Medical Care AG & Co. KGaA (FMS) Stock Forecast & Predictions

Fresenius Medical Care AG & Co. KGaA - ADR FMS: $39.35

Else-Kroener-Strasse 1, Bad Homburg Vor Der Hohe, Hessen, Germany. | Sector: Health Care and Social Assistance | Exchange: NEW YORK STOCK EXCHANGE, INC. | Web: https://www.freseniusmedicalcare.com/

  • Market Cap$22.97B
  • Change (52 Weeks)6.72%
  • Low (52 Weeks)$33.84
  • Fresenius Medical Care AG & Co. KGaA (FMS) Forecast Based on Technical Analysis


    Neutral
    Based on 16 Technical Indicators where 6.25% are on Buy, 43.75% on Sell, and 50.00% Neutral.

    According to the market data, Fresenius Medical Care AG & Co. KGaA (FMS) stock price is $39.35 and the 52 weeks low is $33.84, which means the Fresenius Medical Care AG & Co. KGaA stock price is up 6.72% in the last 12 months.

    Fresenius Medical Care AG & Co. KGaA (FMS) Stock Price is not Trending currently as per the Weekly Chart, which means the price may range between specific high and low levels for the next few months, unless some significant changes take place in the market performance or news.

    Technical Indicators are algorithms that are used mostly by Technical traders to predict the price action of a stock.

    Based on our analysis of 16 technical indicators, 6.25% are indicating that FMS Stock price might rise further, 43.75% indicating that FMS Stock price might fall, and 50.00% are in a neutral position.

    Based on these technical algorithms, overall FMS stock price has a Neutral Signal, which means the stock price has the potential to move either up or down, depending on the nature of consolidating market phase, since majority of indicators are providing a neutral signal.

    Fresenius Medical Care AG & Co. KGaA (FMS) Stock Forecast By Analysts


    On Hold
    Analysts Recommendations for Fresenius Medical Care AG & Co. KGaA (FMS) is based on 27 Institutional Analyst Ratings where 22.22% are on Strong Buy, 11.11% on Moderate Buy, 59.26% remains on Hold, 3.70% are on Moderate Sell and 3.70% are on Strong Sell.

    Out of 27 Institutional Analysts, majority recommended FMS stock as On Hold. This means investors are recommended to hold their existing positions if any, otherwise, the recommendation is neither to buy nor sell at this stage. Since most investors and traders follow analyst ratings closely, this can be a potentially driving factor for the future stock price of Fresenius Medical Care AG & Co. KGaA.

    Fresenius Medical Care AG & Co. KGaA (FMS) Stock Price Prediction By Analysts


    HighLowAverage
    $42.00$36.36$38.31
    $38.312.64% Downside
    Updated: 2021-04-22 00:00:00

    The Average Price target for FMS set by the institutional analysts is $38.31 where High Estimate is $42.00, Median $37.74 and Low $36.36.

    The average price target for FMS by Institutional Analysts is $38.31, which is 2.64% Downside from the current price. So according to the Institutional Analysts, FMS Stock might be a bit overvalued at this stage and there’s potential for downside.

    However, although Institutional Analysts set their price targets after extensive research, they’re not always correct. After all, the market is mostly driven by investors speculation and emotion than just concrete numbers.

    Fresenius Medical Care AG & Co. KGaA (FMS) Stock Forecast Based on Investor Sentiment


    Very Positive

    Based on 388,226 investor portfolio.

    Our algorithm has analysed 388,226 investor portfolio with FMS stock holdings and found that 99.50% of them are bullish. Which means the Investor Sentiment is mostly Very Positive.

    This shows most investors are very optimistic about FMS and holding their positions hoping for a further rise in the stock price and more profit.

    Fresenius Medical Care AG & Co. KGaA (FMS) Stock Forecasts By Institutional Analysts


    Analyst
    Recommendation
    Action
    Goldman SachsBuyInitiated
    JPMorgan ChaseNeutralInitiated
    Independent Research GmbHBuyInitiated
    Credit SuisseNeutralInitiated
    Berenberg BankBuyInitiated
    UBSBuyInitiated
    Sanford BernsteinNeutralInitiated
    JPMorgan ChaseNeutralInitiated
    Deutsche BankNeutralInitiated
    Independent Research GmbHBuyInitiated
    Goldman SachsBuyInitiated
    JefferiesSellInitiated
    JPMorgan ChaseBuyInitiated
    UBSBuyInitiated
    Credit SuisseNeutralInitiated
    Independent Research GmbHBuyInitiated
    Kepler CheuvreuxBuyInitiated
    Goldman SachsBuyInitiated
    JefferiesNeutralInitiated
    Independent Research GmbHBuyInitiated
    Berenberg BankBuyInitiated
    Warburg ResearchNeutralInitiated
    JPMorgan ChaseBuyInitiated
    BarclaysBuyInitiated
    SunTrust Robinson HumphreyBuyMaintained
    Morgan StanleyNeutralInitiated
    Sanford BernsteinNeutralInitiated
    SunTrust Robinson HumphreyBuyMaintained
    Independent Research GmbHNeutralInitiated
    JefferiesBuyInitiated
    Goldman SachsBuyInitiated
    Berenberg BankBuyInitiated
    BarclaysBuyInitiated
    SunTrust Robinson HumphreyBuyMaintained
    Sanford BernsteinNeutralInitiated
    Berenberg BankBuyInitiated
    Sanford BernsteinNeutralInitiated
    Berenberg BankBuyInitiated
    Nord/LBBuyInitiated
    JPMorgan ChaseBuyInitiated
    UBSBuyInitiated
    Independent Research GmbHNeutralInitiated
    CFRABuyUpgraded
    UBSBuyInitiated
    Kepler CheuvreuxNeutralInitiated
    Credit SuisseNeutralInitiated
    Warburg ResearchNeutralInitiated
    BarclaysBuyInitiated
    Berenberg BankBuyInitiated
    Deutsche BankBuyInitiated
    BarclaysBuyInitiated
    JefferiesBuyInitiated
    JPMorgan ChaseBuyInitiated
    Morgan StanleySellInitiated
    JPMorgan ChaseBuyInitiated
    Sanford BernsteinNeutralInitiated
    JPMorgan ChaseBuyInitiated
    Goldman SachsBuyInitiated
    Bank of AmericaBuyInitiated
    RedburnNeutralDowngraded
    BTIGNeutralDowngraded
    BarclaysOverweightUpgraded
    UBSBuyUpgraded
    DZ BankHoldDowngraded
    HSBCBuyUpgraded
    Deutsche BankBuyUpgraded
    NomuraBuyInitiated
    UBSBuyUpgraded
    SunTrust Robinson HumphreyBuyMaintained
    PiperJaffrayNeutralMaintained
    Societe GeneraleHoldDowngraded
    HSBCNeutralUpgraded
    Morgan StanleyOverweightUpgraded
    Exane BNP ParibasNeutralDowngraded
    BarclaysOverweightUpgraded
    RBC CapitalSector PerformDowngraded
    PiperJaffrayNeutralDowngraded
    JefferiesHoldDowngraded

    Fresenius Medical Care AG & Co. KGaA (FMS) Stock Earning Per Share (EPS) Forecast / Estimate


    $0.879
    The average consensus EPS for FMS is $0.879 with a high estimate of $1.029 and Low of $0.745 for the period 2021-06-30 and based on 3 Institutional Analysts.

    Last Quarter


    Actual
    Estimate
    Date
    $1.27$1.21048499999999982020-12-31


    The latest average Earning Per Share Estimate for Fresenius Medical Care AG & Co. KGaA is $0.88, which is lower than FMS's last EPS, $1.27. This means that Analysts are expecting Fresenius Medical Care AG & Co. KGaA to report lower earnings. This can drive share prices lower since the investors have negative sentiment about market performance of Fresenius Medical Care AG & Co. KGaA.

    Earning Per Share (EPS) History


    Actual
    Estimate
    Date
    $1.27$1.21048499999999982020-12-31
    $1.21$1.15947999999999982020-09-30
    $1.2$1.09023442020-06-30
    $0.95$0.8728422020-03-31
    $1.36$1.32310000000000022019-12-31
    $1.21$1.08701252019-09-30
    $0.92$0.96802442019-06-30
    $1.04$0.93450252019-03-31
    $1.33$1.2752262018-12-31
    $1.01$1.07425622018-09-30
    $1$1.05309672018-06-30
    $0.91$0.970612018-03-31
    $1.28$1.3296652017-12-31
    $1.01$0.96153012017-09-30
    $0.88$0.90599020000000012017-06-30
    $0.9999$0.91012112017-03-31
    $1.17907$1.11793872016-12-31
    $0.97669$0.98197249999999992016-09-30
    $0.85024$0.85283392016-06-30
    $0.67957$0.69788982016-03-31
    $0.95019$1.0326242015-12-31
    $0.7733$0.80975742015-09-30
    $0.71443$0.76438820000000012015-06-30
    $0.61317$0.67258930000000012015-03-31
    $0.889$0.94759212014-12-31
    $0.67169$0.72956342014-09-30
    $0.60517$0.62072582014-06-30
    $0.4963$0.53434052014-03-31
    $0.87415$0.73884532013-12-31
    $0.71693$0.61736249999999992013-09-30
    $0.68149$0.63744132013-06-30
    $0.56082$0.60757562013-03-31
    $0.82478$0.80831312012-12-31
    $0.70409$0.7315432012-09-30
    $0.70989$0.75068249999999992012-06-30
    $0.61009$0.58712312012-03-31
    $0.75844$0.81005032011-12-31
    $0.65152$0.67860892011-09-30
    $0.59798$0.61148432011-06-30
    $0.53366$0.50622212011-03-31

    What is Analyst Ratings & Price Targets?

    The analysts provide Buy, Sell or Hold ratings after extensive research of a companies financial reports, listening to conference calls and some of them even get in contact with upper management of the company to get an overall picture of operation.

    Although institutional Analyst’s are not always correct, their ratings are followed by millions of traders around the world and they can heavily influence trading activities for a company.

    As a retail investor, going through analyst ratings will instantly provide you an idea if the stock is worth buying. Top Analysts also provide their price targets. It’s a prediction of where the stock price might go based on their analysis.

    The best way to analyze price targets is to combined average price targets of major analysts. If the average price target is much higher than the current price of the stock, then the probability of a stock going up is also high.

    What is Technical Analysis?

    Technical Analysis refers to analyzing a stock's price over a period of time. In the financial market, past price patterns are one of the strongest indicators of an asset's future performance.

    In easier terms, millions of traders use Live Charts to watch the stock prices, it is actually a single source of truth for most traders. When a stock's price reaches a significant price level/pattern in the chart, millions of traders take buy/sell positions from those levels.

    As a regular investor, one of the easiest ways to check technical analysis of a stock is through Technical Indicators. Technical Indicators are programmed algorithms that monitor price changes in the Charts and indicate Buy/Sell based on market conditions.

    Some Technical Indicators can be very powerful (e.g SMA) and some can be pretty useless. Stock research tools like iTradely heavily simplify the technical analysis process for the investors by showing Buy/Sell/Neutral ratings combined from 17 powerful technical indicators, all in one page.

    What is Earnings Per Share (EPS) and Why is it Important?

    EPS, or Earning Per Share, can tell a lot about a stock’s performance. It’s calculated by dividing a company’s profit by the number of outstanding shares of its common stocks.

    In layman’s term, earnings is an indicator of a company’s profitability. Higher the earnings, the more profitable a company is.
    Some traders pick stocks solely based on EPS or earnings Analysis, it is a very powerful indicator of a stock’s price.

    Before you buy a stock, check the company’s earnings History and Surprises. A Surprise happens when a company reports a much higher or lower actual earnings/EPS than the forecasted earnings/EPS.

    If a company reports higher EPS surprises consistently, analysts keep raising their estimates, traders become more confident in the company, driving the share price higher.

    What is Stock Sentiment?

    Stock Sentiment refers to how people speculating about the stock or what kind of trading position investors are often taking.

    There are different kinds of sentiments you can find online for a company, this includes Investor Sentiment (Percentage of investors buying or selling), News Sentiment (Is the company getting positive or negative impressions from the Press?), Social Sentiment (The overall trends about the company in social media, is it negative or positive?).